VALIDATING AN INDUSTRY-SPONSORED MODEL COMPARING THE COST-EFFECTIVENESS OF ATYPICAL ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA

被引:0
|
作者
Graham, Christopher N. [1 ]
Mauskopf, Josephine [1 ]
Lawson, Anthony H. [2 ]
Ascher-Svanum, Haya [2 ]
Bruhn, David [2 ]
Watson, Peter R. [2 ]
机构
[1] RTI Hlth Solut Res, Res Triangle Pk, NC USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
关键词
D O I
10.1016/j.schres.2010.02.722
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:398 / 399
页数:2
相关论文
共 50 条
  • [21] LONG-TERM COST-EFFECTIVENESS OF ATYPICAL ANTIPSYCHOTICS FOR SCHIZOPHRENIA IN THE UNITED STATES
    Rajagopalan, K.
    O'Day, K.
    Meyer, K.
    Pikalov, A. A., III
    Loebel, A.
    VALUE IN HEALTH, 2012, 15 (04) : A87 - A87
  • [22] Cost-effectiveness of antipsychotics for outpatients with chronic schizophrenia
    Obradovic, M.
    Mrhar, A.
    Kos, M.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (12) : 1979 - 1988
  • [23] COST-EFFECTIVENESS OF INJECTABLE ATYPICAL LONG-ACTING ANTIPSYCHOTICS FOR CHRONIC SCHIZOPHRENIA IN POLAND
    Hemels, M.
    Einarson, T. R.
    Zilbershtein, R.
    Schubert, A.
    Skrzekowska-Baran, I
    Van Impe, K.
    VALUE IN HEALTH, 2013, 16 (07) : A548 - A548
  • [24] Methods and applications of cost-effectiveness modeling for atypical antipsychotics
    Revicki, D. A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S39 - S39
  • [25] Cost-effectiveness of atypical antipsychotics in acute bipolar mania
    McGarry, LJ
    Bird, A
    Thompson, D
    Wang, P
    Martin, SC
    Weinstein, MC
    VALUE IN HEALTH, 2003, 6 (03) : 352 - 352
  • [26] Cost-effectiveness of antipsychotics for outpatients with chronic schizophrenia - Response
    Kos, M.
    Mrhar, A.
    Obradovic, M.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (07) : 1120 - +
  • [27] Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
    Antonio J García-Ruiz
    Lucía Pérez-Costillas
    Ana C Montesinos
    Javier Alcalde
    Itziar Oyagüez
    Miguel A Casado
    Health Economics Review, 2 (1)
  • [28] Comments on 'Cost-effectiveness of antipsychotics for outpatients with chronic schizophrenia'
    Koh, S. S.
    Meyer, J. M.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (07) : 1120 - 1120
  • [29] Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
    Garcia-Ruiz, Antonio J.
    Perez-Costillas, Lucia
    Montesinos, Ana C.
    Alcalde, Javier
    Oyagueez, Itziar
    Casado, Miguel A.
    HEALTH ECONOMICS REVIEW, 2012, 2
  • [30] COST-EFFECTIVENESS OF PALIPERIDONE PALMITATE VERSUS OTHER ANTIPSYCHOTICS FOR THE TREATMENT OF SCHIZOPHRENIA IN FRANCE
    Doutriaux, A.
    Cognet, M.
    Druais, S.
    Lancon, C.
    Samalin, L.
    Levy, P.
    Godet, A.
    Guillon, P.
    VALUE IN HEALTH, 2014, 17 (07) : A459 - A459